126 related articles for article (PubMed ID: 1588470)
21. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
22. Visual results in children treated for macular retinoblastoma.
Watts P; Westall C; Colpa L; MacKeen L; Abdolell M; Gallie B; Héon E
Eye (Lond); 2002 Jan; 16(1):75-80. PubMed ID: 11913894
[TBL] [Abstract][Full Text] [Related]
23. Visual prognosis of retinoblastoma in the posterior pole treated with primary chemotherapy plus local treatments.
Kim JM; Kim JH; Kim SJ; Park KD; Shin HY; Ahn HS; Yu YS
Korean J Ophthalmol; 2010 Dec; 24(6):347-52. PubMed ID: 21165233
[TBL] [Abstract][Full Text] [Related]
24. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment.
Shields CL; Shields JA; De Potter P; Minelli S; Hernandez C; Brady LW; Cater JR
Ophthalmology; 1993 Feb; 100(2):216-24. PubMed ID: 8437830
[TBL] [Abstract][Full Text] [Related]
25. Socioeconomic impact of modern multidisciplinary management of retinoblastoma.
Wilson MW; Haik BG; Rodriguez-Galindo C
Pediatrics; 2006 Aug; 118(2):e331-6. PubMed ID: 16882777
[TBL] [Abstract][Full Text] [Related]
26. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
Bartuma K; Pal N; Kosek S; Holm S; All-Ericsson C
Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
[TBL] [Abstract][Full Text] [Related]
27. Visual prognosis in macular retinoblastomas.
Lam BL; Judisch GF; Sobol WM; Blodi CF
Am J Ophthalmol; 1990 Sep; 110(3):229-32. PubMed ID: 2396646
[TBL] [Abstract][Full Text] [Related]
28. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
29. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
30. Visual results and ocular complications following radiotherapy for retinoblastoma.
Egbert PR; Donaldson SS; Moazed K; Rosenthal AR
Arch Ophthalmol; 1978 Oct; 96(10):1826-30. PubMed ID: 697618
[TBL] [Abstract][Full Text] [Related]
31. Use of irradiation for therapy of retinoblastoma in children more than 1 year old: the St. Jude Children's Research Hospital experience and review of literature.
Fontanesi J; Pratt CB; Hustu HO; Coffey D; Kun LE; Meyer D
Med Pediatr Oncol; 1995 May; 24(5):321-6. PubMed ID: 7700185
[TBL] [Abstract][Full Text] [Related]
32. Predictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma.
Narang S; Mashayekhi A; Rudich D; Shields CL
Clin Exp Ophthalmol; 2012; 40(7):736-42. PubMed ID: 22300311
[TBL] [Abstract][Full Text] [Related]
33. Radiation regression patterns in treated retinoblastoma: 7 to 21 years later.
Abramson DH; Gerardi CM; Ellsworth RM; McCormick B; Sussman D; Turner L
J Pediatr Ophthalmol Strabismus; 1991; 28(2):108-12. PubMed ID: 2051287
[TBL] [Abstract][Full Text] [Related]
34. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.
Greenwald MJ; Strauss LC
Ophthalmology; 1996 Dec; 103(12):1989-97. PubMed ID: 9003332
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy of retinoblastoma. A review of 63 children treated with different irradiation techniques.
Amendola BE; Lamm FR; Markoe AM; Karlsson UL; Shields J; Shields CL; Augsburger J; Brady LW; Woodleigh R; Miller C
Cancer; 1990 Jul; 66(1):21-6. PubMed ID: 2354405
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy.
Gallie BL; Budning A; DeBoer G; Thiessen JJ; Koren G; Verjee Z; Ling V; Chan HS
Arch Ophthalmol; 1996 Nov; 114(11):1321-8. PubMed ID: 8906022
[TBL] [Abstract][Full Text] [Related]
37. Retinoblastoma. The long-term appearance of radiated intraocular tumors.
Abramson DH; McCormick B; Fass D; Ellsworth RM; Gerardi C; Servodidio CA; Romanella A
Cancer; 1991 Jun; 67(11):2753-5. PubMed ID: 2025838
[TBL] [Abstract][Full Text] [Related]
38. Treatment of retinoblastoma by precision megavoltage radiation therapy.
Schipper J; Tan KE; van Peperzeel HA
Radiother Oncol; 1985 Feb; 3(2):117-32. PubMed ID: 3920733
[TBL] [Abstract][Full Text] [Related]
39. Radiation therapy for retinoblastoma: a retrospective review of 120 patients.
Pradhan DG; Sandridge AL; Mullaney P; Abboud E; Karcioglu ZA; Kandil A; Mustafa MM; Gray AJ
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):3-13. PubMed ID: 9300734
[TBL] [Abstract][Full Text] [Related]
40. Proton radiation therapy for the treatment of retinoblastoma.
Mouw KW; Sethi RV; Yeap BY; MacDonald SM; Chen YL; Tarbell NJ; Yock TI; Munzenrider JE; Adams J; Grabowski E; Mukai S; Shih HA
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):863-9. PubMed ID: 25227498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
